DLCLHealthcare Service Provider
Dr Lalchandani Labs Ltd — Cash Flow Statement
₹14.81
+0.00%
Dr Lalchandani Labs Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.29 Cr | -0.33 Cr | -0.30 Cr | 0.91 Cr | — |
| Repayment Of Debt | -0.26 Cr | -3.05 Cr | -0.06 Cr | -0.02 Cr | — |
| Capital Expenditure | -0.15 Cr | -0.12 Cr | -0.30 Cr | -1.10 Cr | — |
| End Cash Position | 3.30 Cr | 2.29 Cr | 3.10 Cr | 3.53 Cr | — |
| Beginning Cash Position | 2.29 Cr | 3.10 Cr | 3.53 Cr | 2.89 Cr | — |
| Changes In Cash | 1.00 Cr | -0.81 Cr | -0.43 Cr | 0.64 Cr | — |
| Financing Cash Flow | 0.50 Cr | -1.59 Cr | -0.23 Cr | 0.16 Cr | — |
| Interest Paid Cff | -0.09 Cr | -0.38 Cr | -0.88 Cr | -0.48 Cr | — |
| Net Issuance Payments Of Debt | 0.59 Cr | -1.21 Cr | 0.64 Cr | 0.65 Cr | — |
| Net Short Term Debt Issuance | 0.85 Cr | 1.85 Cr | -0.06 Cr | 0.67 Cr | — |
| Net Long Term Debt Issuance | -0.26 Cr | -3.05 Cr | 0.70 Cr | -0.02 Cr | — |
| Long Term Debt Payments | -0.26 Cr | -3.05 Cr | — | -0.02 Cr | — |
| Investing Cash Flow | 0.06 Cr | 1.00 Cr | -0.20 Cr | -1.53 Cr | — |
| Interest Received Cfi | 47000.00 | 0.02 Cr | 49000.00 | 8000.00 | — |
| Net Investment Purchase And Sale | 0.14 Cr | -0.17 Cr | 0.00 | — | — |
| Sale Of Investment | 0.14 Cr | — | — | — | — |
| Net PPE Purchase And Sale | -0.08 Cr | 0.96 Cr | -0.30 Cr | -1.10 Cr | — |
| Sale Of PPE | 0.07 Cr | 1.08 Cr | 0.00 | — | — |
| Purchase Of PPE | -0.15 Cr | -0.12 Cr | -0.30 Cr | -1.10 Cr | — |
| Operating Cash Flow | 0.44 Cr | -0.22 Cr | 12000.00 | 2.01 Cr | — |
| Change In Working Capital | -0.59 Cr | -1.64 Cr | 0.03 Cr | -0.02 Cr | — |
| Change In Other Current Liabilities | 0.04 Cr | -2.03 Cr | 0.90 Cr | 0.85 Cr | — |
| Change In Other Current Assets | 0.04 Cr | 0.15 Cr | 0.23 Cr | -0.23 Cr | — |
| Change In Payable | -0.27 Cr | -0.11 Cr | -0.09 Cr | 0.47 Cr | — |
| Change In Inventory | 0.14 Cr | 0.09 Cr | 0.03 Cr | -0.88 Cr | — |
| Change In Receivables | -0.55 Cr | 0.26 Cr | -0.75 Cr | -0.23 Cr | — |
| Other Non Cash Items | 0.08 Cr | 0.37 Cr | 0.87 Cr | 0.48 Cr | — |
| Deferred Tax | -0.01 Cr | 0.00 | — | — | — |
| Depreciation And Amortization | 0.56 Cr | 0.62 Cr | 0.66 Cr | 0.59 Cr | — |
| Depreciation | 0.56 Cr | 0.62 Cr | 0.59 Cr | 0.51 Cr | — |
| Gain Loss On Sale Of PPE | -16000.00 | -0.19 Cr | 0.00 | — | — |
| Net Income From Continuing Operations | 0.40 Cr | 0.62 Cr | -1.56 Cr | 1.29 Cr | — |
| Repurchase Of Capital Stock | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance Of Debt | — | 1.85 Cr | 0.70 Cr | 0.67 Cr | 1.89 Cr |
| Issuance Of Capital Stock | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | -1000.00 | — | -1000.00 |
| Net Common Stock Issuance | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Payments | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Issuance | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Short Term Debt Issuance | — | 1.85 Cr | — | 0.67 Cr | 0.71 Cr |
| Purchase Of Investment | — | -0.17 Cr | 0.00 | — | — |
| Taxes Refund Paid | — | 0.00 | 0.00 | -0.33 Cr | -0.31 Cr |
| Amortization Cash Flow | — | 0.07 Cr | 0.07 Cr | 0.08 Cr | 0.04 Cr |
| Short Term Debt Payments | — | — | -0.06 Cr | — | — |
| Long Term Debt Issuance | — | — | 0.70 Cr | — | 1.18 Cr |
| Net Other Investing Changes | — | — | 1000.00 | 1000.00 | — |
| Net Other Financing Charges | — | — | — | -1000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Lalchandani Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.